Merck, Pfizer Skin Cancer Drug Receives Breakthrough Status

FDA granted Avelumab* a Breakthrough Therapy designation for the treatment of patients with metastatic Merkel cell carcinoma
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news